HR Notices From December 4
Visit CBS Detroit's
Ashtin Adds Pharmacist: The JB Ashtin Group Inc. announced that Jill McCollam has joined the company’s Scientific Services department as director. McCollam comes to JB Ashtin from Janssen Pharmaceuticals where she was Senior Medical Science Liaison and Senior Medical Project Scientist in their Analgesia division. At JB Ashtin, McCollam will be responsible for collaborating with clients and thought leaders to develop relevant and engaging scientific communications programs. In addition to providing extensive project management expertise, McCollam will also serve as medical writer, delivering high-quality scientific/medical content to all clients. Plymouth-based JB Ashtin Group is a recognized leader in the medical communications industry. For more information, visit www.jbashtin.com.
Perrigo Appoints Industry Veteran To Executive Vice President And General Manager, Rx: Allegan-based Perrigo Co. Tuesday announced the appointment of Douglas Boothe as executive vice president and general manager, Perrigo Pharmaceuticals, effective Jan. 1. Sharon Kochan, who previously held this position, has been managing the business in the interim since accepting the newly created role of executive vice president and general manager, international in July. Prior to joining Perrigo, Boothe was CEO of Actavis Inc., where he was responsible for all aspects of the company’s generics business in North America and Latin America, including sales, marketing, supply chain, quality, finance, legal, IT, regulatory affairs, human resources and intellectual property. He also has served in strategic planning and business development leadership roles for Alpharma Inc., Pharmacia Corp. and Xerox Corp. Boothe has a bachelor’s degree in mechanical and aerospace engineering from Princeton University and an MBA in marketing management and strategic planning from the University of Pennsylvania’s Wharton School of Business. From its beginnings as a packager of generic home remedies in 1887, Perrigo has grown to become a leading global provider of quality, affordable healthcare products. The company develops, manufactures and distributes over-the-counter and generic prescription pharmaceuticals, nutritional products and active pharmaceutical ingredients and is the world’s largest manufacturer of OTC pharmaceutical products for the store brand market. More at www.perrigo.com.